「message」の検索結果
71件：21～25件目を表示
もしかして
-
Publications | Research & Development | SENJU Pharmaceutica
Efficacy and safety of topical azithromycin therapy in patients with blepharitis and meibomian gland dysfunction Jun Shimazaki 1,2, Gakushi Kito 3, Mizuka Kamoi 2, Yoshiyuki Satake 1,4 1 Department of
http://www.senju.co.jp/english/rd/thesis/ -
Mytear HARD LENS WETTING SOLUTION | OTC Products, etc. | Products | SENJU Pharmaceutical
Designated quasi-drugs Mytear® HARD LENS WETTING SOLUTION Lubricates lenses, allows smooth insertion CHARACTERISTICS Viscous liquid forms a thin layer on the surface of hard or rigid gas permeable len
http://www.senju.co.jp/english/products/wettingsolution.html -
研究開発の取り組み | 千寿製薬株式会社
R & D activities R & D Pipeline Clinical trial information Publications Meetings of the Minds Business Collaboration Inquiries licensing★senju.co.jp* When contacting us by e-mail, please chang
http://www.senju.co.jp/english/rd/ -
MytearV | OTC Products, etc. | Products | SENJU Pharmaceutical
Category 2 OTC medicines Mytear® V Resolves redness of the eye and provides healthy and clear eyes. CHARACTERISTICS Compounded with "tetrahydrozoline hydrochloride", a component to relieve r
http://www.senju.co.jp/english/products/mytearv.html -
R&D Pipeline | Research & Development | SENJU Pharmaceutica
PROGRESS OF DEVELOPMENT Disclosuring of information after Phase 1 DrugIndicationStatus (Region) Difluprednateinflammation associated with ocular surgery, UveitisApproved (Russia) Pranoprofeninflammati
http://www.senju.co.jp/english/rd/pipeline.html